15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering Zoetis Inc, 6 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $85.00 to $190.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $119.50 sits 54% above the current $77.59. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.85 next quarter toward $7.39 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Moderate Buy
Strong Buy00%
Buy646%
Hold754%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to Zoetis Inc.
As of Jul, 6 of 13 firms rate ZTS a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ZTS EPS & revenue forecast
EPS · NEXT QUARTER
$1.85
Range $1.79 – $1.90 · 13 analysts · +9% YoY
Next period, 13 analysts expect Zoetis Inc to earn $1.85 a share (range $1.79 – $1.90), versus $1.70 a year earlier. Full-year consensus is $6.86, growing to $7.39 the year after.
REVENUE · NEXT QUARTER
$2.5B
Range $2.5B – $2.5B · 13 analysts · +4% YoY
Revenue is expected to reach $2.5B (range $2.5B – $2.5B), +4.4% year-over-year. Full-year consensus is $9.8B, rising to $10.1B next year.
Top analysts covering Zoetis Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ZTS.
#1
Balaji Prasad
Barclays · Rank #147
Buy
$244.00+214.5% to target
Overall win rate
44%
+ Follow
#2
Jonathan Block
Stifel · Rank #172
Hold
$85.00+9.6% to target
Overall win rate
42%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #227
Hold
$135.00+74.0% to target
Overall win rate
31%
+ Follow
#4
Scott Schoenhaus
Keybanc · Rank #345
Hold
No targeton ZTS
Overall win rate
29%
+ Follow
#5
AA
Andrea Alfonso
UBS
Hold
$99.00+27.6% to target
Coverage
—
+ Follow
ZTS stock forecast FAQ
What is ZTS's average 12-month price target?+
The 11 analysts with a live target average $119.50 for Zoetis Inc over the next 12 months, ranging from a $190.00 high to a $85.00 low.
Is ZTS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 13 analyst ratings, 6 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ZTS?+
The Street-high target is $190.00, and the Street-low is $85.00 (Barclays). The average of all 11 active targets is $119.50.
How many Wall Street analysts cover ZTS?+
13 analysts have an active rating on Zoetis Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering ZTS?+
Among analysts who currently cover ZTS, Balaji Prasad of Barclays has the strongest overall Quantellect track record (Rank #147). Their current call is Buy with a $244.00 target.
What is Zoetis Inc's projected EPS for next quarter?+
The consensus estimate is $1.85 per share (range $1.79 – $1.90) across 13 analysts. Full-year EPS is projected at $6.86, rising to $7.39 the following year.
How much revenue is Zoetis Inc expected to report next quarter?+
Consensus revenue is $2.5B (range $2.5B – $2.5B). Full-year revenue is projected at $9.8B, growing to $10.1B next year.
Have analysts been upgrading or downgrading ZTS lately?+
As of Jul, 6 of 13 firms rate ZTS a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ZTS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
